Skip to main content
OpenTrials

Clinical trial condition

Nephrosis

Explore clinical trials studying Nephrosis. Study availability and eligibility vary by location and protocol.

165 public trials 54 recruiting studies
Refine in advanced search Browse all conditions

Nephrosis trial results

Recruiting

A Trial to Assess the Efficacy and Safety of Obinutuzumab in Treating Adults With Minimal Change Disease (MCD)

NCT07710157

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +6 more
Locations
  • Division of Nephrology, Department of Internal Medicine, Medical University of Graz Graz, Austria
  • Department of Internal Medicine IV, Nephrology and Hypertension Innsbruck, Austria
  • 6. Medizinische Abteilung mit Nephrologie & Dialyse, Klinik Ottakring Vienna, Austria
  • Laboratory of Immunology, Nice University Hospital (CHU de Nice), Côte d'Azur University Nice, France
View Trial Details
Recruiting

Study of WAL0921 in Patients With Glomerular Kidney Diseases

NCT06466135

Conditions
Autoimmune Diseases, Diabetes Complications, Diabetes Mellitus, +18 more
Locations
  • Academic Medical Research Institute Los Angeles, California, United States
  • Colorado Kidney and Vascular Care Denver, Colorado, United States
  • D & H Tamarac Research Center Tamarac, Florida, United States
  • Fides Clinical Research Atlanta, Georgia, United States
View all 50 locations
View Trial Details
Recruiting

Belimumab With Rituximab for Primary Membranous Nephropathy

NCT03949855

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations
  • University of Alabama at Birmingham School of Medicine: Division of Nephrology Birmingham, Alabama, United States
  • University of Arkansas Little Rock, Arkansas, United States
  • University of California San Francisco San Francisco, California, United States
  • Stanford University School of Medicine: Division of Nephrology Stanford, California, United States
View all 20 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

NCT06500702

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Focal Segmental Glomerulosclerosis, +10 more
Locations
  • Investigational Site Number : 8400007 Birmingham, Alabama, United States
  • Investigational Site Number : 8400015 Orange, California, United States
  • Investigational Site Number : 8400012 San Francisco, California, United States
  • Investigational Site Number : 8400025 Tampa, Florida, United States
View all 71 locations
View Trial Details

Related conditions